NCT00767273已完成不适用
Pilot Study to Investigate the Role of Metabolic Imaging in Predicting Tumor Response and Outcome After Therapy for Pancreatic Cancer
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Evaluate the performance of the novel imaging methods
研究概览
简要总结
To test the ability of new imaging techniques to monitor and predict response of pancreatic cancer to radiation and/or chemotherapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients (>18) with histologically confirmed adenocarcinomas of the pancreas with a - treatment plan consisting of definitive or palliative radiation therapy and/or chemotherapy with or without surgery.
- •Negative urine pregnancy test if a woman of child-bearing potential (WOCBP).
- •WOCBP must be using an adequate method of contraception to avoid pregnancy throughout the study period.
- •All patients will be evaluated in a uniform manner at the Stanford GI Combined Modality Tumor Board to determine eligibility.
排除标准
- •Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
- •2. Any concurrent malignancy other than non-melanomaskin cancer, or carcinomainsitu of the cervix. Patients with a previous malignancy without evidence of disease for >5 years will be allowed to enter the trial.
- •3. WOCBP who is pregnant or breastfeeding.
- •Inability to sign written consent.
结局指标
主要结局
Evaluate the performance of the novel imaging methods
次要结局
- Correlate FLT activity with clinical outcomes
研究者
Albert Koong
Associate Professor of Radiation Oncology
Stanford University
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Investigating Targetable Metabolic Pathways Sustaining Pancreatic CancerPancreatic Ductal AdenocarcinomaNCT05296421Rutgers, The State University of New Jersey16
已完成
不适用
Evaluation of PET/MRI in Patients With Pancreatic AdenocarcinomaAdenocarcinoma PancreasNCT02028377Washington University School of Medicine25
已完成
不适用
Optical and Biochemical Biomarkers in Early Pancreatic CancerPancreatic CancerNCT03404661Mayo Clinic346
终止
不适用
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CARectal CancerNCT00394615Stanford University15
进行中（未招募）
不适用
Predicting Effective Therapy in Pancreatic CancerPancreatic AdenocarcinomaPancreatic CancerNCT03033927Memorial Sloan Kettering Cancer Center74